AR012638A1 - Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional - Google Patents
Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacionalInfo
- Publication number
- AR012638A1 AR012638A1 ARP980102025A ARP980102025A AR012638A1 AR 012638 A1 AR012638 A1 AR 012638A1 AR P980102025 A ARP980102025 A AR P980102025A AR P980102025 A ARP980102025 A AR P980102025A AR 012638 A1 AR012638 A1 AR 012638A1
- Authority
- AR
- Argentina
- Prior art keywords
- pregnan
- manufacture
- onas
- medicinal product
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional a un mamífero que necesita de dicha terapiaque comprende administrar una cantidad progestacionalmente efectiva de una sal farmacéuticamente aceptable de 3-sulfatoéster de 5alfa-pregnan-3beta-ol-20-onaa dicho mamífero.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85056797A | 1997-05-02 | 1997-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012638A1 true AR012638A1 (es) | 2000-11-08 |
Family
ID=25308504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102025A AR012638A1 (es) | 1997-05-02 | 1998-04-30 | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0981349B1 (es) |
JP (1) | JP2001525807A (es) |
KR (1) | KR20010012157A (es) |
CN (1) | CN1254283A (es) |
AR (1) | AR012638A1 (es) |
AT (1) | ATE227130T1 (es) |
AU (1) | AU739146B2 (es) |
BR (1) | BR9809376A (es) |
CA (1) | CA2289006A1 (es) |
DE (1) | DE69809223T2 (es) |
DK (1) | DK0981349T3 (es) |
ES (1) | ES2186153T3 (es) |
PT (1) | PT981349E (es) |
WO (1) | WO1998050042A1 (es) |
ZA (1) | ZA983705B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1270718C (zh) | 1998-03-11 | 2006-08-23 | 托布乔恩·贝克斯托罗姆 | 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用 |
SE0104423D0 (sv) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
EP1868614B1 (en) | 2005-03-24 | 2012-08-08 | Emory University | Dosage regimen for the treatment of a traumatic brain injury with progesterone |
US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
WO2006117592A1 (en) * | 2005-04-29 | 2006-11-09 | Inserm | Methods of modulating nuclear receptors |
CN102753181B (zh) | 2010-01-14 | 2014-09-17 | 优麦克里尼穆德公司 | 具有改进的储存特性和溶解度特性的包含3-β-羟基-5-α-孕烷-20-酮的药物组合物 |
-
1998
- 1998-04-28 EP EP98918789A patent/EP0981349B1/en not_active Expired - Lifetime
- 1998-04-28 DE DE69809223T patent/DE69809223T2/de not_active Expired - Fee Related
- 1998-04-28 CN CN98804719A patent/CN1254283A/zh active Pending
- 1998-04-28 ES ES98918789T patent/ES2186153T3/es not_active Expired - Lifetime
- 1998-04-28 CA CA002289006A patent/CA2289006A1/en not_active Abandoned
- 1998-04-28 WO PCT/US1998/008456 patent/WO1998050042A1/en not_active Application Discontinuation
- 1998-04-28 JP JP54815598A patent/JP2001525807A/ja active Pending
- 1998-04-28 DK DK98918789T patent/DK0981349T3/da active
- 1998-04-28 AT AT98918789T patent/ATE227130T1/de not_active IP Right Cessation
- 1998-04-28 PT PT98918789T patent/PT981349E/pt unknown
- 1998-04-28 BR BR9809376-2A patent/BR9809376A/pt not_active IP Right Cessation
- 1998-04-28 KR KR19997010102A patent/KR20010012157A/ko not_active Application Discontinuation
- 1998-04-28 AU AU71647/98A patent/AU739146B2/en not_active Ceased
- 1998-04-30 ZA ZA9803705A patent/ZA983705B/xx unknown
- 1998-04-30 AR ARP980102025A patent/AR012638A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU7164798A (en) | 1998-11-27 |
AU739146B2 (en) | 2001-10-04 |
CA2289006A1 (en) | 1998-11-12 |
KR20010012157A (ko) | 2001-02-15 |
ES2186153T3 (es) | 2003-05-01 |
DK0981349T3 (da) | 2003-03-10 |
BR9809376A (pt) | 2000-07-04 |
JP2001525807A (ja) | 2001-12-11 |
ZA983705B (en) | 1999-11-01 |
CN1254283A (zh) | 2000-05-24 |
ATE227130T1 (de) | 2002-11-15 |
DE69809223T2 (de) | 2003-07-24 |
WO1998050042A1 (en) | 1998-11-12 |
DE69809223D1 (de) | 2002-12-12 |
EP0981349B1 (en) | 2002-11-06 |
EP0981349A1 (en) | 2000-03-01 |
PT981349E (pt) | 2003-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
AR012376A1 (es) | Formulacion de gel para la aplicacion topica | |
CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
ES2062392T3 (es) | Medicamentos que comprenden salmeterol y fluticasona. | |
BR9604880A (pt) | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica | |
ES2159591T3 (es) | Composicion de liberacion controlada. | |
YU37301A (sh) | Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa | |
ATE216220T1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
AR011114A1 (es) | COMPOSICIoN FARMACÉUTICA LIBRE DE LACTOSA EN FORMA GRANULADA O EN MEZCLA PARA EL TRATAMIENTO DE DESoRDENES INDUCIDOS POR HISTAMINA. | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
BR9708706B1 (pt) | composiÇço farmacÊutica para administraÇço intravenosa a um paciente | |
PT957899E (pt) | Forma de dosagem para proporcionar um medicamento numa dose crescente | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
AR023699A1 (es) | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
FR2767526B1 (fr) | Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant | |
AR002191A1 (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion | |
AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
BR0010092A (pt) | Composto, preparação farmacêutica para a administração oral ou parenteral, uso de um composto, e, uso da preparação farmacêutica | |
AR010344A1 (es) | Uso de equilenina o una sal farmaceuticamente aceptable del ester de equilenina-3-sulfato para la manufactura de un medicamento util para inhibir otratar patologias inducidas por los radicales libres y composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |